3 completed. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 1 | Completed 1 |
Follow Oncothyreon Canada Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer PX-866 - Prostate Cancer | Phase 2 | Completed | NCIC Clinical Trials Group | 68 | 2011-09-09 | 2023-08-22 |
| Safety and Immunological Response Rate Study of THERATOPE® Vaccine in Metastatic Breast Cancer Patients THERATOPE® vaccine - Breast Neoplasms | Phase 2 | Completed | Oncothyreon Canada Inc. | 2002-08-01 | 2008-01-23 | |
| Vaccine Therapy in Treating Women With Metastatic Breast Cancer Detox-B adjuvant, THERATOPE STn-KLH vaccine, keyhole limpet hemocyanin - Breast Cancer | Phase 3 | Completed | Oncothyreon Canada Inc. | 950 | 1999-01-01 | 2013-03-26 |
Breast Neoplasms (2) · Prostatic Neoplasms (1)
Cyclophosphamide (1) · PX-866 (1) · detox adjuvant (1) · keyhole-limpet hemocyanin (1) · sialyl-Tn antigen-keyhole-limpet hemocyanin conjugate (1)
Canada (2) · United States (1)
Kim Chi (1) · Sebastien Hotte (1)